|
|
Alan L. Rothman
J Clin Invest. 2004;
113(7):946
doi:10.1172/JCI21512
Abstract |
Full text
| PDF
D
engue is an expanding public health problem, and an effective vaccine remains elusive. This review discusses how the significant influence of sequential infection with different dengue virus serotypes on the severity of disease can be viewed in terms of beneficial and detrimental effects of heterologous immunity. A more complete understanding of these effects is likely to be critical for predicting optimal vaccine-induced immune responses.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(19)
| Title and authors |
Publication |
Year |
Immune Response to Dengue Virus and Prospects for a Vaccine*
Brian R. Murphy, Stephen S. Whitehead
|
Annu. Rev. Immunol.
|
2011 |
Development of a Method to Control the RNA Extraction and Reverse Transcription Steps for the Detection of Dengue Virus Present in Human Blood Samples
Cristian A. Galván, Osvaldo C. Elbarcha, Eduardo J. Fernández, Dante M. Beltramo, Néstor W. Soria
|
Genetic Testing and Molecular Biomarkers
|
2011 |
Theoretical Aspects of Immunity
Michael W. Deem, Pooya Hejazi
|
Annu. Rev. Chem. Biomol. Eng.
|
2010 |
Meta-analysis of all immune epitope data in the Flavivirus genus: inventory of current immune epitope data status in the context of virus immunity and immunopathology.
Kerrie Vaughan, Jason Greenbaum, Martin Blythe, Bjoern Peters, Alessandro Sette
|
Viral Immunology
|
2010 |
Patterns of Gene Transcript Abundance in the Blood of Children with Severe or Uncomplicated Dengue Highlight Differences in Disease Evolution and Host Response to Dengue Virus Infection
Hoang Truong Long, Martin L. Hibberd, Tran Tinh Hien, Nguyen Minh Dung, Tran Van Ngoc, Jeremy Farrar, Bridget Wills, Cameron P. Simmons
|
J INFECT DIS
|
2009 |
Essential role of platelet-activating factor receptor in the pathogenesis of Dengue virus infection.
Danielle G Souza, Caio T Fagundes, Lirlandia P Sousa, Flavio A Amaral, Rafael S Souza, Adriano L Souza, Erna G Kroon, Daniela Sachs, Fernando Q Cunha, Eugenij Bukin, Alena Atrasheuskaya, George Ignatyev, Mauro M Teixeira
|
Proc. Natl. Acad. Sci. U.S.A.
|
2009 |
Production and Characterization of Monoclonal Antibody Specific to Recombinant Dengue Multi-Epitope Protein
Ajay Vinayak Abhyankar, Rakesh Bhargava, Asha Mukul Jana, Ajay Kumar Sahni, P.V. Lakshmana Rao
|
Hybridoma
|
2008 |
Monocytes, but not T or B cells, are the principal target cells for dengue virus (DV) infection among human peripheral blood mononuclear cells
Zhihua Kou, Matthew Quinn, Huiyuan Chen, W.W. Shanaka I. Rodrigo, Robert C. Rose, Jacob J. Schlesinger, Xia Jin
|
J. Med. Virol.
|
2008 |
Computational analysis and identification of amino acid sites in dengue E proteins relevant to development of diagnostics and vaccines
Raja Mazumder, Zhang-Zhi Hu, C. R. Vinayaka, Jose-Luis Sagripanti, Simon D. W. Frost, Sergei L. Kosakovsky Pond, Cathy H. Wu
|
Virus Genes
|
2007 |
Multiple Antigenic Peptides as Vaccine Platform for the Induction of Humoral Responses Against Dengue-2 Virus
Georgios Amexis, Neal S. Young
|
Viral Immunology
|
2007 |
|
